TNF and chronic obstructive pulmonary disease: By inhibiting the JAK-STAT pathway, JAK inhibitors could potentially reduce inflammation and attenuate cytokine production levels, such as levels of cytokines like IL-6, TNF-α, and others involved in COPD.